This is the evolution of a procedure designed and developed by IVI that uses stem cell therapy to help to restore ovarian function.
This procedure consists of activating stem cells present in other parts of the body that with sufficient biological stimulation can become cells with ovarian functions. The injection of enriched plasma into these cells gives us the possibility of restoring the physiological processes involved in follicular recruitment.
Stem cell therapy has had significant success in the field of regenerative medicine in the last two decades. Stem cells stand out for their ability to develop into other cell types. In addition, in many tissues they act as a kind of internal repair system, since they are continually dividing to replace other cells that may disappear, hence they can be used in infertility treatment, especially in aspects of ovarian insufficiency. ASCOT-1 is the evolution of a technique designed and developed by IVI. With the administration of drugs that mobilize bone marrow stem cells, these will increase their concentration in peripheral blood and produce growth factors, which gives us the possibility of restoring the physiological processes involved in follicular recruitment to recover ovarian function.